18283399

Source:http://linkedlifedata.com/resource/pubmed/id/18283399

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0002736, umls-concept:C0006055, umls-concept:C0034380, umls-concept:C0037036, umls-concept:C0332161
pubmed:issue	4
pubmed:dateCreated	2008-5-8
pubmed:abstractText	Sialorrhea is a disabling problem in bulbaronset amyotrophic lateral sclerosis (ALS). Botulinum toxin (BTX) type A and B have been proposed as alternatives to traditional treatments.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0423161
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Botulinum Toxins, http://linkedlifedata.com/resource/pubmed/chemical/Neuromuscular Agents, http://linkedlifedata.com/resource/pubmed/chemical/Parasympatholytics, http://linkedlifedata.com/resource/pubmed/chemical/rimabotulinumtoxinB
pubmed:status	MEDLINE
pubmed:month	Apr
pubmed:issn	0340-5354
pubmed:author	pubmed-author:CoelhoMiguelM, pubmed-author:CostaJoãoJ, pubmed-author:EvangelistaTeresinhaT, pubmed-author:FerreiraJoaquimJ, pubmed-author:RochaMaria LuzML, pubmed-author:de CarvalhoMamedeM
pubmed:issnType	Print
pubmed:volume	255
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	545-50
pubmed:dateRevised	2010-11-18
pubmed:meshHeading	pubmed-meshheading:18283399-Aged, pubmed-meshheading:18283399-Amyotrophic Lateral Sclerosis, pubmed-meshheading:18283399-Botulinum Toxins, pubmed-meshheading:18283399-Humans, pubmed-meshheading:18283399-Infant, pubmed-meshheading:18283399-Male, pubmed-meshheading:18283399-Mastication, pubmed-meshheading:18283399-Middle Aged, pubmed-meshheading:18283399-Neuromuscular Agents, pubmed-meshheading:18283399-Pain, pubmed-meshheading:18283399-Parasympathetic Nervous System, pubmed-meshheading:18283399-Parasympatholytics, pubmed-meshheading:18283399-Patient Satisfaction, pubmed-meshheading:18283399-Pilot Projects, pubmed-meshheading:18283399-Prospective Studies, pubmed-meshheading:18283399-Quality of Life, pubmed-meshheading:18283399-Salivary Glands, pubmed-meshheading:18283399-Sialorrhea, pubmed-meshheading:18283399-Treatment Outcome
pubmed:year	2008
pubmed:articleTitle	Botulinum toxin type-B improves sialorrhea and quality of life in bulbaronset amyotrophic lateral sclerosis.
pubmed:affiliation	Serviço de Neurologia (Piso 7), Hospital de Santa Maria, Av. Prof. Egas Moniz, 1649-035 Lisboa. joaoncosta@sapo.pt
pubmed:publicationType	Journal Article, Clinical Trial